Evidence map›Paper›PMID 41479004›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Methods for Isolating and Analyzing the HLA Class I Immunopeptidome.

Martha Nikopaschou, Georgia Rouni, Martina Samiotaki

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Martha NikopaschouDepartment of Chemistry, National and Kapodistrian University of Athens, Athens, Greece.
Georgia RouniBiomedical Sciences Research Center "Alexander Fleming,", Institute for Bioinnovation, Vari, Greece.
Martina SamiotakiBiomedical Sciences Research Center "Alexander Fleming,", Institute for Bioinnovation, Vari, Greece. samiotaki@fleming.gr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunopeptidomics is a mass spectrometry-based technique, crucial for characterizing the peptide repertoire displayed by Class I Human Leukocyte Antigens (HLA-I). This repertoire, known as the immunopeptidome, is central to adaptive immunity, as it facilitates T cell recognition of infected or malignant cells that present abnormal peptides. Understanding the immunopeptidome and the rules behind its generation is therefore essential for deciphering antigen presentation mechanisms and uncovering new diagnostic markers and therapeutic targets in infectious diseases, cancer and autoimmunity.This chapter outlines a simple immunopeptidomics protocol, adapted from established workflows with the vision to be accessible and to rely on equipment and reagents commonly available in most biochemistry laboratories, as well as open-source software. Crucially, it includes instructions for the in-house production and purification of the monoclonal antibody needed for HLA-I immunopeptidomics. Practical considerations and tips are also incorporated to empower less experienced researchers, allowing them to successfully apply immunopeptidomics to their own research questions.

Indexed as

Histocompatibility Antigens Class IPeptidesProteomicsHumansMass SpectrometryHistocompatibility Antigens Class IPeptidesImmunoaffinity purificationImmunopeptidomicsLC-MS/MS

Identifiers

PMID41479004

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.